GSK and Pfizer hold out for £60bn bid for consumer health unit
Published
Investors push for higher price or spin-off after rejecting Unilever’s £50bn offer
Full ArticlePublished
Investors push for higher price or spin-off after rejecting Unilever’s £50bn offer
Full ArticleLONDON (AP) — Unilever, the maker of Vaseline skin care products and Dove soap, says it won’t increase a 50 billion-pound..
Analysts express concern over potential deal as GSK investors hold out for £60bn